STOCK TITAN

Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Silk Road Medical, Inc. will report financial results for Q3 2023 on November 8th, 2023. A corresponding audio webcast will be available for participants to listen to the conference call.
Positive
  • Silk Road Medical, Inc. will report financial results for Q3 2023, which could positively impact the stock price if the results exceed expectations.
Negative
  • None.

SUNNYVALE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2023 after market close on Wednesday, November 8th, 2023. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the webcast will be available at https://investors.silkroadmed.com.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com


FAQ

When will Silk Road Medical, Inc. report financial results for Q3 2023?

Silk Road Medical, Inc. will report financial results for Q3 2023 on November 8th, 2023.

Where can participants listen to the conference call?

Participants can listen to the conference call through the audio webcast available at https://investors.silkroadmed.com.

What could positively affect the stock price?

Positive financial results for Q3 2023 could positively impact the stock price if they exceed expectations.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

799.88M
38.29M
5.94%
105.6%
10.44%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SUNNYVALE

About SILK

silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th